The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of subcutaneous (SC) Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc),for the treatment of...
Maze Therapeutics, a company translating genetic insights into new precision medicines, to announced new data from an exploratory muscle biopsy cohort of its Phase...
